Kymera Therapeutics KT-621 BroADen Phase 1b Atopic Dermatitis Trial Results December 8, 2025 8:00 AM EST Click here for Webcast Supporting Materials KT-621 BroADen Phase 1b Atopic Dermatitis Trial Results Presentation, December 2025 10.7 MB
